KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares RepurchasedShort-Term Debt issuances
Ratios

Medtronic (MDT) Shares Repurchased (2016 - 2025)

Historic Shares Repurchased for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $372.0 million.

  • Medtronic's Shares Repurchased rose 2916.67% to $372.0 million in Q4 2025 from the same period last year, while for Oct 2025 it was $950.0 million, marking a year-over-year decrease of 7907.49%. This contributed to the annual value of $3.2 billion for FY2025, which is 5130.96% up from last year.
  • Medtronic's Shares Repurchased amounted to $372.0 million in Q4 2025, which was up 2916.67% from $123.0 million recorded in Q3 2025.
  • In the past 5 years, Medtronic's Shares Repurchased ranged from a high of $2.5 billion in Q3 2024 and a low of $9.0 million during Q1 2021
  • Over the past 5 years, Medtronic's median Shares Repurchased value was $281.0 million (recorded in 2024), while the average stood at $482.0 million.
  • Its Shares Repurchased has fluctuated over the past 5 years, first crashed by 9634.15% in 2021, then skyrocketed by 427777.78% in 2022.
  • Medtronic's Shares Repurchased (Quarter) stood at $429.0 million in 2021, then tumbled by 67.13% to $141.0 million in 2022, then soared by 60.28% to $226.0 million in 2023, then rose by 27.43% to $288.0 million in 2024, then increased by 29.17% to $372.0 million in 2025.
  • Its Shares Repurchased was $372.0 million in Q4 2025, compared to $123.0 million in Q3 2025 and $274.0 million in Q2 2025.